Anixa Biosciences Inc (NASDAQ: ANIX) stock closed at $3.97 on 10/28/24 after a major increase of 22.2%. Moreover, trading volume in this advance was exceptionally high at 859% of normal. The stock has risen 31.9% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, ANIX is expected to continue to be a modest Value Eraser.
Anixa Biosciences has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Anixa Biosciences has a very low Power Rating of 13 and a very low Appreciation Score of 8, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment